Sale price$375.24
Select a Configuration

Special Order Item

Est. Delivery: 
<p>Earn%20[points_amount]%20when%20completing%20this%20purchase.</p>

Description

Teleflex Medical Teleflex Lma Madgic Laryngo-Tracheal Mucosal Atomization Device. A versatile choice to administer medication across the entire upper airway and beyond the vocal cords. The MADgic Device is not prefilled, so you can select the type of medication and exact dosing desired. And with its malleable stylet, you can attain precise, targeted delivery specific to your patient's anatomy.
SKU MPN OPTION DESCRIPTION EST. TO SHIP
TFX-MAD600 MAD600 Atomizer, 3 mL Syringe, 25/bx Laryngo-Tracheal Atomizer, 3 mL Syringe, 25/bx (Continental US Only) 4-5 Weeks
TFX-MAD720 MAD720 Atomizer, Pediatric, w/out Syringe, 25/bx Laryngo-Tracheal Atomizer, Pediatric, w/out Syringe, 25/bx (Continental US Only) 4-5 Weeks

Frequently asked questions

Is medication delivery precise and targeted?

Yes, the Teleflex LMA MADgic device is specifically engineered for highly precise and targeted medication delivery across the laryngo-tracheal mucosa and upper airway. This precision is achieved through its specialized design:

  • Malleable Stylet: The integrated stylet can be manipulated and shaped by the clinician, allowing for customized administration and precise positioning tailored to the patient’s unique anatomy.
  • Broad, Targeted Reach: It effectively administers medication across the entire upper airway, extending delivery even past the vocal cords.
  • Customizable Dosing: Since the device is not prefilled, clinicians have the flexibility to select the exact medication type and precise dosage required for individualized treatment.
What specialized device configurations are offered?

The Teleflex LMA MADgic Atomization Device is available in two specialized configurations, both packaged in boxes of 25 units. A core benefit is that the devices are not prefilled, providing clinicians full autonomy over medication choice and precise dosage.

The two configurations are:

  • Standard Atomizer (SKU TFX-MAD600): This option includes the atomizer unit bundled with a 3 mL syringe.
  • Pediatric Atomizer (SKU TFX-MAD720): This smaller version, designed for pediatric use, is supplied without a syringe.
What configurations are available?

The LMA MADgic device is offered in two primary configurations, both packaged at 25 units per box (25/bx), ensuring versatility for clinical needs:

  • Standard Configuration: Includes the atomizer device and a 3 mL syringe.
  • Pediatric Configuration: Includes the atomizer device only, and does not include a syringe.

A key functional benefit is that the device is supplied non-prefilled, granting clinicians full control over the specific medication and exact dosage for precise, targeted delivery throughout the upper airway.

Does the device use a malleable stylet?

Yes, the Teleflex LMA MADgic device includes a malleable stylet.

This key feature allows for highly precise and targeted medication delivery. Clinicians can tailor the positioning of the device based on the patient’s specific anatomy to ensure the medication reaches the entire upper airway, including areas beyond the vocal cords.

Is the MADgic designed for precise medication delivery?

Yes, the Teleflex LMA MADgic device is specifically engineered for highly precise and targeted delivery of medication to the laryngo-tracheal mucosa. This level of precision is achieved through key design features:

  • Malleable Stylet: Features an integrated malleable stylet, allowing clinicians to customize the tip’s position for anatomically tailored, targeted medication administration.
  • Extended Coverage: The device is capable of delivering therapeutic agents across the entire upper airway, extending past the vocal cords.
  • Customizable Dosing: Since the device is not prefilled, clinicians have full control over selecting the medication type and precise dosage required for the patient.
Is the stylet malleable for precise targeting?

Yes, the Teleflex MADgic device is specifically equipped with a malleable stylet to ensure highly precise and targeted medication administration.

This crucial feature provides clinicians with superior control, allowing them to:

  • Match Patient Anatomy: Meticulously shape the stylet for delivery tailored to the individual patient’s airway structure.
  • Achieve Broad Coverage: Effectively administer medication across the entire upper airway, extending delivery effectiveness even beyond the vocal cords.
  • Ensure Accuracy: Guarantee exact placement of the chosen topical medication.
Can I customize the medication and dosage with the MADgic device?

Yes, the Teleflex LMA MADgic device is not pre-filled, which allows you to select the specific medication and dosage needed for each patient. This provides flexibility in treatment.

Which device configuration includes a syringe?

The inclusion of a syringe depends on the specific configuration selected:

  • The Standard configuration (Atomizer, 3 mL Syringe, 25/bx) is supplied with a 3 mL syringe.
  • The Pediatric configuration (Atomizer, Pediatric, w/out Syringe, 25/bx) is supplied without a syringe.
Is the Teleflex LMA MADgic device reusable?

The Teleflex LMA MADgic Laryngo-Tracheal Mucosal Atomization Device is a single-use, factory-new product.

This design helps ensure sterility and precise functionality for targeted medication delivery to the upper airway. The device is supplied in boxes containing 25 units.

How does the MADgic device achieve targeted delivery?

The MADgic device is specifically engineered for precise and targeted drug delivery to the laryngo-tracheal mucosa and the entire upper airway, including areas past the vocal cords. Its targeting capabilities rely on two key design features:

  • Malleable Stylet: The device features a malleable stylet that clinicians can manipulate and shape to match the patient’s unique anatomy. This allows for anatomically specific placement, ensuring targeted application of the medication.
  • Customizable Dosing: Since the device is supplied non-prefilled, medical professionals have complete autonomy over selecting the exact therapeutic agent and the precise quantity to be administered, which is crucial for customized treatment plans.